Cargando…
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study †
In this study, we evaluated the presence of residual disease in patients with axial spondyloarthritis (axSpA) in remission/low disease activity (LDA) status. This cross-sectional post-hoc analysis of the QUASAR study involving 23 rheumatology centres across Italy included adults with axSpA classifie...
Autores principales: | D’Angelo, Salvatore, Salvarani, Carlo, Marando, Francesca, Gualberti, Giuliana, Novelli, Lucia, Curradi, Giacomo, Tripepi, Giovanni, Pitino, Annalisa, Ramonda, Roberta, Marchesoni, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224866/ https://www.ncbi.nlm.nih.gov/pubmed/35743623 http://dx.doi.org/10.3390/jcm11123553 |
Ejemplares similares
-
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study
por: Marchesoni, Antonio, et al.
Publicado: (2021) -
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study
por: Lubrano, Ennio, et al.
Publicado: (2020) -
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study
por: Ramonda, Roberta, et al.
Publicado: (2022) -
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study
por: Zabotti, Alen, et al.
Publicado: (2021) -
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
por: Atzeni, Fabiola, et al.
Publicado: (2021)